Joanne Wuensch
Stock Analyst at Citi
(2.37)
# 3,072
Out of 5,078 analysts
1282
Total ratings
51.3%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Rated: Buy | $125 → $122 | $103.70 | +17.65% | 90 | Oct 22, 2026 | |
| IART Integra LifeSciences Holdings | Rated: Hold | $15 → $14 | $11.91 | +17.55% | 32 | Oct 22, 2026 | |
| DXCM DexCom | Reiterated: Buy | $105 | $77.94 | +34.72% | 68 | Oct 21, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $89.07 | +23.50% | 84 | Oct 21, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $26 | $18.34 | +41.77% | 7 | Oct 21, 2026 | |
| PODD Insulet | Reiterated: Hold | $150 | $149.01 | +0.66% | 47 | Oct 21, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $20 | $17.43 | +14.74% | 48 | Oct 21, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $500 | $452.29 | +10.55% | 38 | Oct 20, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $307.15 | - | 61 | Oct 7, 2026 | |
| BAX Baxter International | Reiterated: Hold | $28 → $27 | $25.30 | +6.72% | 62 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 | $198.91 | +4.57% | 41 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $17.47 | +20.21% | 19 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $50 → $48 | $45.69 | +5.06% | 82 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 → $71 | $71.45 | -0.63% | 28 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 → $303 | $263.81 | +14.86% | 64 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $95.41 | +15.29% | 86 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $350 | $324.39 | +7.89% | 44 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $10 | $8.99 | +11.23% | 29 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $99 | $98.56 | +0.45% | 64 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $61.21 | -1.98% | 58 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $230.50 | -0.22% | 1 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 → $123 | $118.51 | +3.79% | 30 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $188 → $225 | $178.88 | +25.78% | 45 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $63.80 | +44.20% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $121.27 | +29.46% | 58 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 | $453.67 | +3.60% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $412 | $392.15 | +5.06% | 1 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 → $96 | $126.54 | -24.13% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.15 | $1.83 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 55.24 → CHF 56.89 | CHF 57.94 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $252.86 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $30.03 | n/a | 2 | Sep 26, 2016 |
Abbott Laboratories
Oct 22, 2026
Rated: Buy
Price Target: $125 → $122
Current: $103.70
Upside: +17.65%
Integra LifeSciences Holdings
Oct 22, 2026
Rated: Hold
Price Target: $15 → $14
Current: $11.91
Upside: +17.55%
DexCom
Oct 21, 2026
Reiterated: Buy
Price Target: $105
Current: $77.94
Upside: +34.72%
Edwards Lifesciences
Oct 21, 2026
Reiterated: Buy
Price Target: $110
Current: $89.07
Upside: +23.50%
MiniMed Group
Oct 21, 2026
Reiterated: Buy
Price Target: $26
Current: $18.34
Upside: +41.77%
Insulet
Oct 21, 2026
Reiterated: Hold
Price Target: $150
Current: $149.01
Upside: +0.66%
Tandem Diabetes Care
Oct 21, 2026
Reiterated: Hold
Price Target: $20
Current: $17.43
Upside: +14.74%
Intuitive Surgical
Oct 20, 2026
Reiterated: Buy
Price Target: $500
Current: $452.29
Upside: +10.55%
Stryker
Oct 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $307.15
Upside: -
Baxter International
Oct 5, 2026
Reiterated: Hold
Price Target: $28 → $27
Current: $25.30
Upside: +6.72%
Oct 5, 2026
Reiterated: Buy
Price Target: $208
Current: $198.91
Upside: +4.57%
Oct 5, 2026
Rated: Buy
Price Target: $21
Current: $17.47
Upside: +20.21%
Oct 5, 2026
Rated: Hold
Price Target: $50 → $48
Current: $45.69
Upside: +5.06%
Oct 5, 2026
Reiterated: Hold
Price Target: $75 → $71
Current: $71.45
Upside: -0.63%
Oct 5, 2026
Reiterated: Buy
Price Target: $298 → $303
Current: $263.81
Upside: +14.86%
Oct 5, 2026
Reiterated: Buy
Price Target: $110
Current: $95.41
Upside: +15.29%
Oct 5, 2026
Reiterated: Hold
Price Target: $350
Current: $324.39
Upside: +7.89%
Oct 5, 2026
Rated: Hold
Price Target: $8 → $10
Current: $8.99
Upside: +11.23%
Oct 5, 2026
Reiterated: Hold
Price Target: $99
Current: $98.56
Upside: +0.45%
Oct 2, 2026
Reiterated: Hold
Price Target: $60
Current: $61.21
Upside: -1.98%
Sep 21, 2026
Reiterated: Buy
Price Target: $230
Current: $230.50
Upside: -0.22%
Sep 18, 2026
Upgraded: Buy
Price Target: $92 → $123
Current: $118.51
Upside: +3.79%
Aug 14, 2026
Reiterated: Buy
Price Target: $188 → $225
Current: $178.88
Upside: +25.78%
Aug 13, 2026
Upgraded: Buy
Price Target: $92
Current: $63.80
Upside: +44.20%
Aug 13, 2026
Reiterated: Buy
Price Target: $157
Current: $121.27
Upside: +29.46%
Aug 10, 2026
Reiterated: Buy
Price Target: $470
Current: $453.67
Upside: +3.60%
Aug 3, 2026
Reiterated: Buy
Price Target: $412
Current: $392.15
Upside: +5.06%
Jul 8, 2026
Reiterated: Hold
Price Target: $92 → $96
Current: $126.54
Upside: -24.13%
May 23, 2025
Reiterated: Hold
Price Target: $4.15
Current: $1.83
Upside: n/a
Nov 16, 2022
Reiterated: Hold
Price Target: CHF 55.24 → CHF 56.89
Current: CHF 57.94
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $252.86
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $30.03
Upside: n/a